All supplements

Supplement evidence

004 / 575Mineral

Iron

View my plan

The short answer

Treating confirmed iron deficiency and iron-deficiency anemia.

Evidence and scope
Established for an indicated use

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
Fatigue without iron deficiency is not a reason to take iron, and excess does not improve longevity.
Before deciding
Overdose is dangerous; constipation and drug interactions are common. Test before long-term use.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective
Confirmed deficiencyElemental dose is lab- and formulation-specific; many regimens use 40–65 mg once daily or every other day

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFormulation-dependent

Not usefully classified as a fat- or water-soluble vitamin; absorption depends on the salt, extract, delivery system, and meal.

How it is commonly taken

Vitamin C or an empty stomach can increase absorption, but food may improve tolerance.

Do not combine casually

Separate from thyroid medicine, calcium, antacids, and some antibiotics; do not take without evidence of need.

Dose and use source

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

4research papers in this ledger
25unique primary studies represented
1,764unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2024
Mixed or qualifiedPMID 37979057

Daily versus alternate day oral iron therapy in iron deficiency anemia

Hemoglobin and iron indices did not differ clearly; alternate-day dosing produced fewer adverse effects such as nausea, metallic taste, and altered bowel habits.

Study design and methods
Design
Systematic review of randomized and quasi-experimental studies
Population
594 people with iron-deficiency anemia across 7 studies
Intervention
Daily versus alternate-day oral iron
Outcome
Hemoglobin, iron indices, and adverse effects
Open research record
2023
Mixed or qualifiedPMID 38021373 · NCT05105438

Alternate day versus consecutive day oral iron supplementation in iron-depleted women

At equal total doses, alternate-day dosing did not raise ferritin more, but caused fewer gastrointestinal effects and less iron deficiency at six months.

Study design and methods
Design
Double-masked randomized placebo-controlled trial
Population
150 young Swiss women with ferritin at or below 30 μg/L
Intervention
100 mg iron daily for 90 days versus the same total dose on alternate days over 180 days
Outcome
Ferritin, gastrointestinal effects, hepcidin, and persistent deficiency

Study period: 2021–2022

Funding or conflict note: Funded by the Swiss National Science Foundation; authors reported no competing interests.

Open research record
2018
Mixed or qualifiedPMID 29626044

Efficacy of iron supplementation on fatigue and physical capacity in non-anaemic iron-deficient adults

Iron modestly reduced self-reported fatigue, but did not improve objective physical capacity, including maximal oxygen consumption.

Study design and methods
Design
Systematic review and meta-analysis of randomized trials
Population
1,170 iron-deficient but non-anemic adults across 18 unique trials
Intervention
Oral, intramuscular, or intravenous iron versus placebo or active therapy
Outcome
Self-reported fatigue and objective physical capacity

Funding or conflict note: The review reported no competing interests.

Open research record
2015
Safety signalPMID 25700159

Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults

Ferrous sulfate increased gastrointestinal effects versus placebo and intravenous iron. This overlapping safety review is excluded from the evidence totals.

Study design and methods
Design
Systematic review and meta-analysis of 43 randomized trials
Population
6,831 adults receiving ferrous sulfate, placebo, or intravenous iron
Intervention
Oral ferrous sulfate versus placebo or intravenous iron
Outcome
Gastrointestinal adverse effects

Funding or conflict note: Two authors disclosed consulting and a patent related to an iron-supplement material.

Open research record
Unscreened discovery appendix—not evidence1,758 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. Response of reticulocyte and red blood cell indices to single-dose intravenous iron in pregnant women with moderate iron deficiency anemia: secondary analysis of the RAPIDIRON trial.Somannavar MS, Mehta S, Sharma DK et al. · 2026 · The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · PMID 42045095Open on PubMed
  2. Assessment of the safety and efficacy of micronized encapsulated ferric pyrophosphate in patients with iron deficiency anaemia: a phase-IV open-label clinical study.Almajali B, Kv G, Kuppusamy G et al. · 2026 · Artificial cells, nanomedicine, and biotechnology · PMID 41604507Open on PubMed
  3. Association between hematologic response to iron therapy and risk of stillbirth in pregnant singletons with moderate iron deficiency anemia.Boelig RC, Georgieff M, Thind S et al. · 2026 · American journal of obstetrics and gynecology · PMID 42069102Open on PubMed
  4. Bovine Lactoferrin Compared With Ferrous sulfate for Treating Iron-Deficiency Anemia in Bangladeshi Women-A Randomized Controlled Trial.Huda TM, Islam S, Ali NB et al. · 2026 · The Journal of nutrition · PMID 42302886Open on PubMed
  5. Enteral iron dose effect on iron storage, intestinal barrier, and gut microbiome in preterm infants: a randomized clinical trial.Gibbons JA, Nelson RM, Dabrowski CN et al. · 2026 · The American journal of clinical nutrition · PMID 42264152Open on PubMed
  6. Intravenous Ferric Carboxymaltose in Ischemic vs Nonischemic Heart Failure and Iron Deficiency: Insights From FAIR-HF2.Khan MS, Butler J, Karakas M et al. · 2026 · Journal of cardiac failure · PMID 41027507Open on PubMed
  7. Impact of oral iron dosing regimens on iron biomarkers during pregnancy: insights from the PANDA trial.Haynes S, Armitage AE, Roy NBA et al. · 2026 · Blood advances · PMID 42024457Open on PubMed
  8. Efficacy and safety of intravenous ferric carboxymaltose versus oral iron in pregnant women with anemia: a systematic review and meta-analysis.Ali MS, Elfiki M, Elfeky A et al. · 2026 · European journal of clinical pharmacology · PMID 42426275Open on PubMed
  9. Efficacy of Reticulocyte Haemoglobin Equivalent-Guided Versus Transferrin Saturation-Guided Iron Supplement Protocol in Haemodialysis Patients: A Multicenter Cluster Randomized Controlled Trial.Suttaluang C, Phannajit J, Siribamrungwong M et al. · 2026 · Nephrology (Carlton, Vic.) · PMID 42477910Open on PubMed
  10. Assessing the Discriminatory Ability of Hemoglobin Concentration to Predict Iron Stores in Cambodian Females: A Systematic Review and Individual Participant Data Meta-Analysis.Pei LX, Farrell CC, Mlewa SC et al. · 2026 · Advances in nutrition (Bethesda, Md.) · PMID 42297144Open on PubMed
  11. Clinical Trial: Predicting Response to Iron Therapy in Patients With Active Inflammatory Bowel Disease Using Hepcidin and Functional Iron Indices: A Multicentre Randomised Trial.Koppelman LJM, Loveikyte R, Goetgebuer RL et al. · 2026 · Alimentary pharmacology & therapeutics · PMID 42261111Open on PubMed
  12. Assessing the relationship between dietary factors and hair health: A systematic review.Gomes N, Silva N, Teixeira B · 2026 · Nutrition and health · PMID 40836838Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.